AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Wolfers, J Lozier, A Raposo, G Regnault, A Thery, C Masurier, C Flament, C Pouzieux, S Faure, F Tursz, T Angevin, E Amigorena, S Zitvogel, L
Citation: J. Wolfers et al., Tumor-derived exosomes are a source of shared tumor rejection antigens forCTL cross-priming, NAT MED, 7(3), 2001, pp. 297-303

Authors: Valteau-Couanet, D Angevin, E Leboulaire, C Beaussier, PS Bayle, C Hartmann, O Beaujean, F
Citation: D. Valteau-couanet et al., In vitro generation of cytotoxic effecters activated by interleukin 2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adultsand children, BONE MAR TR, 27(8), 2001, pp. 869-875

Authors: Glukhova, L Angevin, E Lavialle, C Cadot, B Terrier-Lacombe, MJ Perbal, B Bernheim, A Goguel, AF
Citation: L. Glukhova et al., Patterns of specific genomic alterations associated with poor prognosis inhigh-grade renal cell carcinomas, CANC GENET, 130(2), 2001, pp. 105-110

Authors: Bernard, J Treton, D Vermot-Desroches, C Boden, C Horellou, P Angevin, E Galanaud, P Wijdenes, J Richard, Y
Citation: J. Bernard et al., Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13R alpha 2 as a decoy receptor for IL13, LAB INV, 81(9), 2001, pp. 1223-1231

Authors: Motta, I Andre, F Lim, A Tartaglia, J Cox, WI Zitvogel, L Angevin, E Kourilsky, P
Citation: I. Motta et al., Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells, J IMMUNOL, 167(3), 2001, pp. 1795-1802

Authors: Ikarashi, Y Mikami, R Bendelac, A Terme, M Chaput, N Terada, M Tursz, T Angevin, E Lemonnier, FA Wakasugi, H Zitovogel, L
Citation: Y. Ikarashi et al., Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: Critical role for B7 in CD1d-dependent NKT cell interferon gamma production, J EXP MED, 194(8), 2001, pp. 1179-1186

Authors: Scardino, A Alves, P Gross, DA Tourdot, S Graff-Dubois, S Angevin, E Firat, H Chouaib, S Lemonier, F Nadler, LM Cardoso, AA Kosmatopoulos, K
Citation: A. Scardino et al., Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors, EUR J IMMUN, 31(11), 2001, pp. 3261-3270

Authors: Gati, A Guerra, N Giron-Michel, J Azzarone, B Angevin, E Moretta, A Chouaib, S Caignard, A
Citation: A. Gati et al., Tumor cells regulate the lytic activity of tumor-specific cytotoxic T lymphocytes by modulating the inhibitory natural killer receptor function, CANCER RES, 61(8), 2001, pp. 3240-3244

Authors: Ibrahim, EC Guerra, N Lacombe, MJT Angevin, E Chouaib, S Carosella, ED Caignard, A Paul, P
Citation: Ec. Ibrahim et al., Tumor-specific up-regulation of the nonclassical class IHLA-G antigen expression in renal carcinoma, CANCER RES, 61(18), 2001, pp. 6838-6845

Authors: Chouaib, S Echchakir, H Angevin, E Guerra, N Kosmatopoulos, K Caignard, A Lim, A Baron, V Ferradini, L Mami-Chouaib, F
Citation: S. Chouaib et al., Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring, B CANCER, 88(8), 2001, pp. 733-740

Authors: Merad, M Angevin, E Wolfers, T Flament, C Lorenzi, I Triebel, F Escudier, B Zitvogel, L
Citation: M. Merad et al., Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12), J IMMUNOTH, 23(3), 2000, pp. 369-378

Authors: Glukhova, L Lavialle, C Fauvet, D Chudoba, I Danglot, G Angevin, E Bernheim, A Goguel, AF
Citation: L. Glukhova et al., Mapping of the 7q31 subregion common to the small chromosome 7 derivativesfrom two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene, ONCOGENE, 19(6), 2000, pp. 754-761

Authors: Zitvogel, L Angevin, E Tursz, T
Citation: L. Zitvogel et al., Dendritic cell-based immunotherapy of cancer, ANN ONCOL, 11, 2000, pp. 199-205

Authors: Angevin, E Andre, F Zitvogel, L
Citation: E. Angevin et al., Antitumor immunotherapy - Generation of dendritic cells, B CANCER, 87(1), 2000, pp. 107-115

Authors: Guerra, N Guillard, M Angevin, E Echchakir, H Escudier, B Moretta, A Chouaib, S Caignard, A
Citation: N. Guerra et al., Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas, BLOOD, 95(9), 2000, pp. 2883-2889

Authors: Le Cesne, A Vassal, G Farace, F Spielmann, M Le Chevalier, T Angevin, E Valteau-Couanet, D Fizazi, K Cojean, I Llombard, A Tursz, T Escudier, B
Citation: A. Le Cesne et al., Combination interleukin-2 and doxorubicin in advanced adult solid tumors: Circumvention of doxorubicin resistance in soft-tissue sarcoma?, J IMMUNOTH, 22(3), 1999, pp. 268-277

Authors: Durrbach, A Angevin, E Poncet, P Rouleau, M Chavanel, G Chapel, A Thierry, D Gorter, A Hirsch, R Charpentier, B Senik, A Hirsch, F
Citation: A. Durrbach et al., Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro, CANC GENE T, 6(6), 1999, pp. 564-571

Authors: Angevin, E Glukhova, L Pavon, C Chassevent, A Terrier-Lacombe, MJ Goguel, AF Bougaran, J Ardouin, P Court, BH Perrin, JL Vallancien, G Triebel, F Escudier, B
Citation: E. Angevin et al., Human renal cell carcinoma xenografts in SCID mice: Tumorigenicity correlates with a poor clinical prognosis, LAB INV, 79(7), 1999, pp. 879-888

Authors: Gaudin, C Kremer, R Angevin, E Scott, V Triebel, F
Citation: C. Gaudin et al., A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma, J IMMUNOL, 162(3), 1999, pp. 1730-1738

Authors: Escudier, B Le Cesne, A Angevin, E
Citation: B. Escudier et al., Immunotherapeutic approaches in metastatic renal cell carcinoma and melanoma, RESEARCH IN, 1998, pp. 189-204

Authors: Zitvogel, L Fernandez, N Lozier, A Wolfers, J Merad, M Angevin, E Amigorena, S Escudier, B
Citation: L. Zitvogel et al., Immunotherapy for cancer by dendritic cell therapy - From preclinical bases to therapeutic trial designs, EUROCANCER 98, 1998, pp. 289-291
Risultati: 1-21 |